| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |